This publication is unavailable to your account. If you have more privileged account please try to use it or contact with the institution connected to this digital library.
Krawczyk, Katarzyna
2016
Praca doktorska
The analysis of 226 patients, treated with MCL in Hematology Clinic UJCM between 1992-2013, was conducted. 1st line chemotherapy regimens were: CHOP +/- R in 50%, FC+/-R in 23% and intensive induction treatment with cytarabine in 20%. Consolidation with radioimmunotherapy was administered in 34 cases, in 47 – HDT/ASCT. MRD was regularly assessed with flow cytometry in 46 patients. In 75% molecular was detected. Pre-emptive treatment was conducted in 25 cases. 20 of these patients, were treated intensively in the first line, with HDT/ASCT consolidation. Fist line treatment results were: ORR in 71,68%, SD in 5,31%. MCL was refractory in 24,78 % of cases. Median PFS was 28,78 months and median OS 49,9. Treatment results were similar to data from multicenter trials. Survival depended on: type of 1st line treatment and risk factors – MPI. MRD follow-up with flow cytometry is effective in molecular relapse detection, its implementation has an impact on survival in MCL patients. Pre-emptive therapy is effective method of MRD (-) re-achieving (ORR 80%). The use of pre-emptive therapy has a strong impact on OS and PFS among MCL patients, especially in subgroup after consolidation with HDT/ASCT (5-cio letnie OS 100%, vs.65%, PFS 100% vs.45%).
Kraków
2 - studia doktoranckie
hematologia
Wydział Lekarski
Jurczak, Wojciech
oai:dl.cm-uj.krakow.pl:4111
ZB-124961
pol
tylko w bibliotece
Mar 16, 2023
Aug 24, 2016
13
0
http://dl.cm-uj.krakow.pl:8080/publication/4111
RDF
OAI-PMH
Nowakowska-Kopera, Alicja
Pawińska-Wąsikowska, Katarzyna
Zawada, Magdalena
Książek, Teofila
Citation style: chicago-author-date iso690-author-date
This page uses 'cookies'. More information I understand